Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
10.50
+0.09 (0.86%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Elanco Animal Health stock have an average target of 15, with a low estimate of 12 and a high estimate of 19. The average target predicts an increase of 42.86% from the current stock price of 10.50.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
Total | 6 | 6 | 8 | 7 | 7 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Hold Maintains $16 → $12 | Hold | Maintains | $16 → $12 | +14.29% | Mar 6, 2025 |
UBS | UBS | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | +61.90% | Feb 26, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | +23.81% | Feb 26, 2025 |
Stifel | Stifel | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +42.86% | Feb 26, 2025 |
Barclays | Barclays | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +80.95% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
4.58B
from 4.44B
Increased by 3.20%
Revenue Next Year
4.78B
from 4.58B
Increased by 4.26%
EPS This Year
0.84
from 0.68
Increased by 24.22%
EPS Next Year
0.98
from 0.84
Increased by 16.54%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.8B | 5.0B | 5.2B | ||
Avg | 4.6B | 4.8B | 5.0B | ||
Low | 4.4B | 4.5B | 4.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.1% | 8.8% | 9.6% | ||
Avg | 3.2% | 4.3% | 4.2% | ||
Low | -1.9% | -1.0% | -2.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.90 | 1.05 | 1.22 | ||
Avg | 0.84 | 0.98 | 1.11 | ||
Low | 0.78 | 0.89 | 1.00 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 32.8% | 24.3% | 23.7% | ||
Avg | 24.2% | 16.5% | 13.2% | ||
Low | 15.3% | 5.6% | 1.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.